The story of the blue pill offers a complex case study for stakeholders eyeing pharma. While first sales were remarkable, recent patent expiry and the arrival of alternative versions have significantly affected https://craigrlew242430.nizarblog.com/41371306/viagra-and-the-pharmaceutical-industry-a-dangerous-bet